Retinopathy of Prematurity in the 21st Century and the Complex Impact of Supplemental Oxygen

J Clin Med. 2023 Feb 3;12(3):1228. doi: 10.3390/jcm12031228.

Abstract

Retinopathy of prematurity (ROP) is a leading cause of childhood blindness. Not only do the epidemiologic determinants and distributions of patients with ROP vary worldwide, but clinical differences have also been described. The Third Edition of the International Classification of ROP (ICROP3) acknowledges that aggressive ROP (AROP) can occur in larger preterm infants and involve areas of the more anterior retina, particularly in low-resource settings with unmonitored oxygen supplementation. As sub-specialty training programs are underway to address an epidemic of ROP in sub-Saharan Africa, recognizing characteristic retinal pathology in preterm infants exposed to unmonitored supplemental oxygen is important to proper diagnosis and treatment. This paper describes specific features associated with various ROP presentations: oxygen-induced retinopathy in animal models, traditional ROP seen in high-income countries with modern oxygen management, and ROP related to excessive oxygen supplementation in low- and middle-income countries: oxygen-associated ROP (OA-ROP).

Keywords: childhood blindness; global health; global ophthalmology; ophthalmology; oxygen; oxygen-associated retinopathy of prematurity; oxygen-induced retinopathy; pediatric blindness; retinopathy of prematurity; retrolental fibroplasia.